Free Newsletter
Pfizer abandons Viagra suit against Lilly
Free newsletter via e-mail
Tools
Pfizer agreed to drop an 8-year-old patent infringement lawsuit against Eli Lilly over Viagra after a U.S. government agency rejected part of the male impotence drug's patent. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: